FI760948A - - Google Patents

Info

Publication number
FI760948A
FI760948A FI760948A FI760948A FI760948A FI 760948 A FI760948 A FI 760948A FI 760948 A FI760948 A FI 760948A FI 760948 A FI760948 A FI 760948A FI 760948 A FI760948 A FI 760948A
Authority
FI
Finland
Application number
FI760948A
Other languages
Finnish (fi)
Other versions
FI56772B (fi
FI56772C (fi
Inventor
Curt Henry Appelgren
Conny Boerje Bogentoft
John Albert Sjoegren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of FI760948A publication Critical patent/FI760948A/fi
Publication of FI56772B publication Critical patent/FI56772B/fi
Application granted granted Critical
Publication of FI56772C publication Critical patent/FI56772C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
FI760948A 1975-04-09 1976-04-07 Foerfarande foer framstaellning av en beredning foer behandling av onormala tarmtillstaond FI56772C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7504049 1975-04-09
SE7504049A SE7504049L (sv) 1975-04-09 1975-04-09 Colonpreparation

Publications (3)

Publication Number Publication Date
FI760948A true FI760948A (fr) 1976-10-10
FI56772B FI56772B (fi) 1979-12-31
FI56772C FI56772C (fi) 1980-04-10

Family

ID=20324216

Family Applications (1)

Application Number Title Priority Date Filing Date
FI760948A FI56772C (fi) 1975-04-09 1976-04-07 Foerfarande foer framstaellning av en beredning foer behandling av onormala tarmtillstaond

Country Status (12)

Country Link
BE (1) BE840552A (fr)
DE (1) DE2614296A1 (fr)
DK (1) DK153376A (fr)
FI (1) FI56772C (fr)
FR (1) FR2306710A1 (fr)
GB (1) GB1538123A (fr)
IE (1) IE42793B1 (fr)
LU (1) LU74732A1 (fr)
NL (1) NL7603600A (fr)
NO (1) NO761101L (fr)
NZ (1) NZ180552A (fr)
SE (1) SE7504049L (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139715A (en) * 1976-05-14 1977-11-21 Nippon Kayaku Co Ltd Coated granules of alkali polyacrylate
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4444761A (en) * 1981-05-04 1984-04-24 Syntex (U.S.A.) Inc. Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US4521401A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of quinidine
EP0273209B1 (fr) * 1986-12-30 1992-01-15 American Cyanamid Company Composition contenant un polycarbophile
GB8817015D0 (en) * 1988-07-16 1988-08-17 Reckitt & Colmann Prod Ltd Method of treatment
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
CA2082156A1 (fr) * 1990-05-04 1991-11-05 Amnon Sintov Systeme permettant l'administration d'un medicament dans le colon
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
DE9212938U1 (fr) * 1992-09-25 1992-11-26 Boehringer Ingelheim Gmbh, 6507 Ingelheim, De
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
WO2018191752A1 (fr) 2017-04-14 2018-10-18 Gelesis Llc Compositions et méthodes pour le traitement ou la prévention de troubles liés à la perméabilité intestinale

Also Published As

Publication number Publication date
GB1538123A (en) 1979-01-10
DE2614296A1 (de) 1976-10-21
FR2306710A1 (fr) 1976-11-05
NO761101L (fr) 1976-10-12
DK153376A (da) 1976-10-10
FI56772B (fi) 1979-12-31
SE7504049L (sv) 1976-10-10
IE42793L (en) 1976-10-09
NZ180552A (en) 1978-07-28
IE42793B1 (en) 1980-10-22
FI56772C (fi) 1980-04-10
NL7603600A (nl) 1976-10-12
FR2306710B1 (fr) 1979-07-13
LU74732A1 (fr) 1977-02-04
BE840552A (fr) 1976-10-11

Similar Documents

Publication Publication Date Title
FI760948A (fr)
AU495933B2 (fr)
CH592404A5 (fr)
CH600303A5 (fr)
BG22187A1 (fr)
CH597391A5 (fr)
BG22474A1 (fr)
BG22500A1 (fr)
BG22727A1 (fr)
BG26729A1 (fr)
CH27475A4 (fr)
CH576087A5 (fr)
CH577556A5 (fr)
CH582379B5 (fr)
CH584904A5 (fr)
CH585437A5 (fr)
CH597385A5 (fr)
CH587751A5 (fr)
CH588012A5 (fr)
CH588715A5 (fr)
CH589166B5 (fr)
CH590358A5 (fr)
CH590443A5 (fr)
CH590733A5 (fr)
CH586682A5 (fr)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: AB HAESSLE